PlasmaTech Biopharmaceuticals closes underwritten public offering of common … – News-Medical.net

PlasmaTech Biopharmaceuticals closes underwritten public offering of common
News-Medical.net
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase …
PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingCNNMoney

all 3 news articles

…read more

About The Author

error: Content is protected !!